Product Program year 2020 Source: CMS Open Payments

Adlyxin

Biological Endocrinology

NDC 0024-5745-02

Open in the dashboard

General payments

$44,017

10 payments

Research payments

$36,907

15 payments

Through program year 2020, $44,017 in general payments and $36,907 in research payments were reported against Adlyxin (Endocrinology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $44,017 10
2020 Research $36,907 15

Breakdown

Who paid General payments · program year 2020
  1. Sanofi-Aventis U.S. LLC $22,835 4 payments
  2. Sanofi US Services Inc. $21,182 6 payments
Top recipients General payments · program year 2020
  1. Brigham And Womens Hospital Teaching hospital · MA $15,173 34% · 1 payment
  2. Samantha Harris Endocrinology, Diabetes & Metabolism · San Diego, CA $14,680 33% · 1 payment
  3. Vivian Fonseca Endocrinology, Diabetes & Metabolism · New Orleans, LA $4,290 10% · 1 payment
  4. Eugene Wright Internal Medicine · Fayetteville, NC $3,846 9% · 1 payment
  5. Phillip Lieberman Allergy & Immunology · Memphis, TN $3,756 9% · 3 payments

The top 5 of 7 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Endocrinology, Diabetes & Metabolism Internal Medicine $18,970 66% · 2 practitioners
  2. Allergy & Immunology $6,009 21% · 2 practitioners
  3. Internal Medicine $3,865 13% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Massachusetts $15,173 34% · 1 recipient
  2. California $14,680 33% · 1 recipient
  3. Louisiana $4,290 10% · 1 recipient
  4. North Carolina $3,846 9% · 1 recipient
  5. Tennessee $3,756 9% · 1 recipient

The top 5 of 7 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

10 general · 15 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record